COMP <GO>
ELMD vs UNH // RETURN ON INVESTED CAPITAL (ROIC)
Electromed Inc. (NYSE) VS. UnitedHealth Group Incorporated (NYSE) • 15-METRIC TALLY: ELMD 6
— UNH 7
▲ RETURN ON INVESTED CAPITAL (ROIC) LEADER: ELMD
LAST: $27.04 (-2.31%) • MKT CAP: $229.4M
roic
24.10%
LAST: $406.97 (-0.96%) • MKT CAP: $368.83B
roic
11.47%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (ELMD VS. UNH)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | ELMD | UNH | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 78.10% | 88.57% | -10.47 | UNH | /gross-margins <GO> |
| Return on Invested Capital (ROIC) ACTIVE | 24.10% | 11.47% | +12.63 | ELMD | /roic <GO> |
| EV/EBITDA & P/E Valuation | 21.8x | 16.4x | +5.35 | UNH | /valuation <GO> |
| Free Cash Flow Yield | 4.85% | 6.48% | -1.63 | UNH | /fcf-yield <GO> |
| Operating Margin | 15.10% | 4.82% | +10.28 | ELMD | /operating-margins <GO> |
| Net Profit Margin | 11.80% | 3.14% | +8.66 | ELMD | /net-margins <GO> |
| Revenue Growth (YoY) | 17.00% | 6.46% | +10.54 | ELMD | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 2.28% | -2.28 | UNH | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 17.64 | 3.12 | +14.52 | ELMD | /balance-sheet <GO> |
| Piotroski F-Score Quality | 8/9 | 7/9 | +1.00 | ELMD | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | 6.74% | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 48.8 | 59.2 | -10.40 | UNH | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | 0.33 | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | 25.5x | 17.7x | +7.76 | UNH | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $229.4M | $368.83B | -$368.60B | UNH | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | ELMD REV | UNH REV | ELMD GROSS % | UNH GROSS % | ELMD FCF | UNH FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $64.0M | $447.57B | 78.1% | 88.7% | $11.1M | $16.07B |
| FY 2024 | $54.7M | $400.28B | 76.3% | 88.3% | $8.8M | $20.70B |
| FY 2023 | $48.1M | $371.62B | — | 89.6% | $1.3M | $25.68B |
| FY 2022 | — | $324.16B | — | 89.6% | — | $23.40B |
| FY 2021 | — | $287.60B | — | 89.2% | — | $19.89B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
ELMD // BETA —
UNH // BETA 0.33